Trade Capricor Therapeutics Inc - CAPR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.12 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023318% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001096% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 13.21 |
| Open | 12.93 |
| 1-Year Change | 202.81% |
| Day's Range | 12.59 - 12.93 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 13.21 | 0.05 | 0.38% | 13.16 | 13.91 | 12.90 |
| Apr 23, 2025 | 13.09 | -1.07 | -7.56% | 14.16 | 14.31 | 12.79 |
| Apr 22, 2025 | 13.86 | 1.74 | 14.36% | 12.12 | 14.01 | 11.99 |
| Apr 21, 2025 | 11.88 | 0.77 | 6.93% | 11.11 | 12.11 | 11.06 |
| Apr 17, 2025 | 11.19 | 1.03 | 10.14% | 10.16 | 11.27 | 10.05 |
| Apr 16, 2025 | 9.60 | 0.04 | 0.42% | 9.56 | 9.76 | 9.37 |
| Apr 15, 2025 | 9.77 | 0.41 | 4.38% | 9.36 | 9.96 | 9.36 |
| Apr 14, 2025 | 9.34 | 0.07 | 0.76% | 9.27 | 9.56 | 9.06 |
| Apr 11, 2025 | 9.23 | 0.40 | 4.53% | 8.83 | 9.33 | 8.68 |
| Apr 10, 2025 | 8.83 | -0.23 | -2.54% | 9.06 | 9.17 | 8.60 |
| Apr 9, 2025 | 9.36 | 0.89 | 10.51% | 8.47 | 9.49 | 8.06 |
| Apr 8, 2025 | 8.66 | -0.80 | -8.46% | 9.46 | 9.67 | 8.46 |
| Apr 7, 2025 | 9.13 | 0.67 | 7.92% | 8.46 | 9.25 | 8.21 |
| Apr 4, 2025 | 9.00 | 0.23 | 2.62% | 8.77 | 9.21 | 8.29 |
| Apr 3, 2025 | 9.21 | 0.10 | 1.10% | 9.11 | 9.36 | 8.64 |
| Apr 2, 2025 | 9.68 | 0.41 | 4.42% | 9.27 | 9.87 | 9.07 |
| Apr 1, 2025 | 9.42 | 0.02 | 0.21% | 9.40 | 9.80 | 8.84 |
| Mar 31, 2025 | 9.42 | -1.01 | -9.68% | 10.43 | 10.62 | 8.96 |
| Mar 28, 2025 | 11.45 | -0.29 | -2.47% | 11.74 | 11.74 | 10.99 |
| Mar 27, 2025 | 11.76 | -1.46 | -11.04% | 13.22 | 13.65 | 11.76 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 20
- 100
- 500
- 1000
- 10000
Capricor Therapeutics Inc
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases. The company''s lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase II clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with COVID-19; and completed various trials investigating the use of CAP-1002 for the treatment of cardiac conditions, including heart failure and post myocardial infarction with cardiac dysfunction. It is also developing CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in preclinical stage for the potential prevention of COVID-19. Capricor collaborates with Lonza Houston, Inc. for the development of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in Beverly Hills, California.News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com